Skip to main content
Galderma Group AG (GDERF)
OTCMKTS · Delayed Price · Currency is USD
195.75
0.00 (0.00%)
Dec 4, 2025, 4:00 PM EST

Revenue

Fiscal year is January - December.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Neuromodulators Revenue
1.37B1.29B
Log In
Log In
Log In
Fillers & Biostimulators Revenue
1.03B1.01B
Log In
Log In
Log In
Injectable Aesthetics Revenue
2.40B2.30B
Log In
Log In
Log In
Dermatological Skincare Revenue
1.38B1.33B
Log In
Log In
Log In
Therapeutic Dermatology Revenue
881.00M780.00M
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
USA Revenue
1.92B1.81B
Log In
Log In
Log In
International Revenue
2.73B2.60B
Log In
Log In
Log In

Key Performance Indicators

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Neuromodulators Constant Currency Growth
11.80%
Log In
Log In
Log In
Fillers & Biostimulators Constant Currency Growth
7.00%
Log In
Log In
Log In
Injectable Aesthetics Constant Currency Growth
9.60%
Log In
Log In
Log In
Dermatological Skincare Constant Currency Growth
10.70%
Log In
Log In
Log In
Therapeutic Dermatology Constant Currency Growth
6.10%
Log In
Log In
Log In
Total Constant Currency Growth
9.30%
Log In
Log In
Log In